Patients having either chronic kidney disease or high CRP levels (more than 100 IU/l) or hypoalbuminemia could be identified as high-risk patients and treatment must be continued under close monitoring to pick up complications that may lead to mortality. The gene discussed is CRP; the disease is chronic kidney disease.